June 14, 2025
BARCELONA, Spain — All patients with systemic sclerosis (SSc) and mixed connective tissue disease (MCTD) should be screened for interstitial lung disease (ILD), according to new […]
June 14, 2025
BARCELONA, Spain — When to use apremilast and biologics such as adalimumab and infliximab and how to deal with vascular involvement are some of the main […]
June 14, 2025
TOPLINE: Vasoactive vasodilating drugs (VVDs) have differential effects on the progression of systemic sclerosis-associated interstitial lung disease (SSc-ILD), according to a post hoc analysis of prospectively […]
June 13, 2025
BARCELONA, Spain — The JAK inhibitor upadacitinib can effectively treat systemic sclerosis-associated interstitial lung disease (SSc-ILD), according to results from a new clinical trial. Patients treated […]
June 13, 2025
BARCELONA, Spain — Monitoring serum hydroxychloroquine levels could help to ensure that patients with systemic lupus erythematosus (SLE) are being treated with the drug optimally, according […]
June 12, 2025
TOPLINE: In patients with mild psoriasis and no initial musculoskeletal signs, ultrasound bursitis at entheses was associated with the development of inflammatory symptoms suggestive of psoriatic […]
June 11, 2025
TOPLINE: In patients with gout starting allopurinol as a long-term urate-lowering therapy, the prophylactic use of nonsteroidal anti-inflammatory drugs (NSAIDs) was associated with a higher risk […]
June 9, 2025
TOPLINE: The analysis of structural lesions in sacroiliac joints using MRI showed distinct patterns of structural changes across multiple groups, with patients with axial spondyloarthritis (axSpA) […]
June 6, 2025
TOPLINE: Compared with placebo, low-dose methotrexate administered weekly at doses up to 15 mg for 52 weeks did not relieve knee pain or reduce the size […]